Search for Clinical Trial Results

Sponsored By

Acute Myeloblastic Leukemia With Maturation - 179 Studies Found

Status Study
Terminated Study Name: Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Condition:
  • Childhood Acute Myeloblastic Leukemia With Maturation (M2)
  • Chil
    Date: 2002-08-05
    Interventions:
    • Drug: decitabine Given IV
Completed Study Name: Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
Condition:
  • Adult Acute Monoblastic Leukemia (M5a)
  • Adult Acute Monocytic Leukemia (M5b)
  • Drug: idarubicin Given IV
Recruiting Study Name: Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
Condition:
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Monoblastic Leukemia (M5a)
  • Date: 2013-02-26
    Interventions:
    • Drug: mitoxantrone hydrochloride

Recruiting Study Name: CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML
Condition:
  • Acute Myelogenous Leukemia
  • Acute Myeloid Leukemia
  • Date: 2016-10-23
    Interventions: Biological: anti-CD33 CAR-NK cells The allogeneic NK cells (NK-92 cell line for clinical use) are engine
Active, not recruiting Study Name: Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Condition:
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Minimally Differentiated Myeloid Leuk
    Date: 2011-03-01
    Interventions:
    • Drug: caspofungin acetate Give
Completed Study Name: High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2010-08-05
    Interventions:
    • Drug: busulfan Given orally
Terminated Study Name: Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition:
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia
  • Drug: idarubicin Given IV
Completed Study Name: Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
Condition:
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia
  • Drug: cytarabine Given IV
Active, not recruiting Study Name: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition:
  • Adult Acute Minimally Differentiated Myeloid Leukemia (M0)
  • Adult Acute Monoblastic Leukemia
    Date: 2014-01-28
    Interventions:
    • Drug: MEK inhibitor MEK162 Giv
Active, not recruiting Study Name: Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia
Condition:
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Monoblastic Leukemia (M5a)
  • Date: 2013-04-19
    Interventions:
    • Drug: azacitidine Given IV or

Next >>>